3-[4-[3-(3,6-dibromocarbazol-9-yl)-2-oxopropyl]piperazin-1-yl]-N-[[4-[6-[[4-hydroxy-1-[(3R)-3-phenylbutanoyl]piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methyl]propanamide

C51H55Br2N9O5 — CID 166555323

IUPAC3-[4-[3-(3,6-dibromocarbazol-9-yl)-2-oxopropyl]piperazin-1-yl]-N-[[4-[6-[[4-hydroxy-1-[(3R)-3-phenylbutanoyl]piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methyl]propanamide
SMILESC[C@H](CC(=O)N1CCC(O)(Cn2cnc3c(-c4ccc(CNC(=O)CCN5CCN(CC(=O)Cn6c7ccc(Br)cc7c7cc(Br)ccc76)CC5)cc4)n(C)nc3c2=O)CC1)c1ccccc1
InChIInChI=1S/C51H55Br2N9O5/c1-34(36-6-4-3-5-7-36)26-46(65)60-20-17-51(67,18-21-60)32-61-33-55-47-48(50(61)66)56-57(2)49(47)37-10-8-35(9-11-37)29-54-45(64)16-19-58-22-24-59(25-23-58)30-40(63)31-62-43-14-12-38(52)27-41(43)42-28-39(53)13-15-44(42)62/h3-15,27-28,33-34,67H,16-26,29-32H2,1-2H3,(H,54,64)/t34-/m1/s1
InChIKeyZEMSANBUWZTBKM-UUWRZZSWSA-N
MW1033.87 g/mol
LogP6.87
Rot. Bonds15

About 3-[4-[3-(3,6-dibromocarbazol-9-yl)-2-oxopropyl]piperazin-1-yl]-N-[[4-[6-[[4-hydroxy-1-[(3R)-3-phenylbutanoyl]piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methyl]propanamide

3-[4-[3-(3,6-dibromocarbazol-9-yl)-2-oxopropyl]piperazin-1-yl]-N-[[4-[6-[[4-hydroxy-1-[(3R)-3-phenylbutanoyl]piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methyl]propanamide (PubChem CID 166555323) has the molecular formula C51H55Br2N9O5 and a molecular weight of 1033.87 g/mol. Its IUPAC name is 3-[4-[3-(3,6-dibromocarbazol-9-yl)-2-oxopropyl]piperazin-1-yl]-N-[[4-[6-[[4-hydroxy-1-[(3R)-3-phenylbutanoyl]piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methyl]propanamide.

Molecular Properties

Compound Name3-[4-[3-(3,6-dibromocarbazol-9-yl)-2-oxopropyl]piperazin-1-yl]-N-[[4-[6-[[4-hydroxy-1-[(3R)-3-phenylbutanoyl]piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methyl]propanamide
PubChem CID166555323
Molecular FormulaC51H55Br2N9O5
Molecular Weight1033.87 g/mol
Exact Mass1031.27
IUPAC Name3-[4-[3-(3,6-dibromocarbazol-9-yl)-2-oxopropyl]piperazin-1-yl]-N-[[4-[6-[[4-hydroxy-1-[(3R)-3-phenylbutanoyl]piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methyl]propanamide
SMILESC[C@H](CC(=O)N1CCC(O)(Cn2cnc3c(-c4ccc(CNC(=O)CCN5CCN(CC(=O)Cn6c7ccc(Br)cc7c7cc(Br)ccc76)CC5)cc4)n(C)nc3c2=O)CC1)c1ccccc1
InChIInChI=1S/C51H55Br2N9O5/c1-34(36-6-4-3-5-7-36)26-46(65)60-20-17-51(67,18-21-60)32-61-33-55-47-48(50(61)66)56-57(2)49(47)37-10-8-35(9-11-37)29-54-45(64)16-19-58-22-24-59(25-23-58)30-40(63)31-62-43-14-12-38(52)27-41(43)42-28-39(53)13-15-44(42)62/h3-15,27-28,33-34,67H,16-26,29-32H2,1-2H3,(H,54,64)/t34-/m1/s1
InChIKeyZEMSANBUWZTBKM-UUWRZZSWSA-N
XLogP6.87
TPSA150.83 Ų
H-Bond Donors2
H-Bond Acceptors12
Rotatable Bonds15
Heavy Atoms67
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001033.87
LogP ≤ 56.87
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1012

Analyze 3-[4-[3-(3,6-dibromocarbazol-9-yl)-2-oxopropyl]piperazin-1-yl]-N-[[4-[6-[[4-hydroxy-1-[(3R)-3-phenylbutanoyl]piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methyl]propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[4-[3-(3,6-dibromocarbazol-9-yl)-2-oxopropyl]piperazin-1-yl]-N-[[4-[6-[[4-hydroxy-1-[(3R)-3-phenylbutanoyl]piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methyl]propanamide?
The IUPAC name of 3-[4-[3-(3,6-dibromocarbazol-9-yl)-2-oxopropyl]piperazin-1-yl]-N-[[4-[6-[[4-hydroxy-1-[(3R)-3-phenylbutanoyl]piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methyl]propanamide (CID 166555323) is 3-[4-[3-(3,6-dibromocarbazol-9-yl)-2-oxopropyl]piperazin-1-yl]-N-[[4-[6-[[4-hydroxy-1-[(3R)-3-phenylbutanoyl]piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methyl]propanamide.
What is the SMILES notation for 3-[4-[3-(3,6-dibromocarbazol-9-yl)-2-oxopropyl]piperazin-1-yl]-N-[[4-[6-[[4-hydroxy-1-[(3R)-3-phenylbutanoyl]piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methyl]propanamide?
The canonical SMILES for 3-[4-[3-(3,6-dibromocarbazol-9-yl)-2-oxopropyl]piperazin-1-yl]-N-[[4-[6-[[4-hydroxy-1-[(3R)-3-phenylbutanoyl]piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methyl]propanamide is C[C@H](CC(=O)N1CCC(O)(Cn2cnc3c(-c4ccc(CNC(=O)CCN5CCN(CC(=O)Cn6c7ccc(Br)cc7c7cc(Br)ccc76)CC5)cc4)n(C)nc3c2=O)CC1)c1ccccc1.
What is the InChIKey of 3-[4-[3-(3,6-dibromocarbazol-9-yl)-2-oxopropyl]piperazin-1-yl]-N-[[4-[6-[[4-hydroxy-1-[(3R)-3-phenylbutanoyl]piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methyl]propanamide?
The InChIKey is ZEMSANBUWZTBKM-UUWRZZSWSA-N. The full InChI is InChI=1S/C51H55Br2N9O5/c1-34(36-6-4-3-5-7-36)26-46(65)60-20-17-51(67,18-21-60)32-61-33-55-47-48(50(61)66)56-57(2)49(47)37-10-8-35(9-11-37)29-54-45(64)16-19-58-22-24-59(25-23-58)30-40(63)31-62-43-14-12-38(52)27-41(43)42-28-39(53)13-15-44(42)62/h3-15,27-28,33-34,67H,16-26,29-32H2,1-2H3,(H,54,64)/t34-/m1/s1.
What are the key properties of 3-[4-[3-(3,6-dibromocarbazol-9-yl)-2-oxopropyl]piperazin-1-yl]-N-[[4-[6-[[4-hydroxy-1-[(3R)-3-phenylbutanoyl]piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methyl]propanamide?
3-[4-[3-(3,6-dibromocarbazol-9-yl)-2-oxopropyl]piperazin-1-yl]-N-[[4-[6-[[4-hydroxy-1-[(3R)-3-phenylbutanoyl]piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methyl]propanamide has a molecular weight of 1033.87 g/mol, XLogP of 6.87, 15 rotatable bonds, 2 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[4-[3-(3,6-dibromocarbazol-9-yl)-2-oxopropyl]piperazin-1-yl]-N-[[4-[6-[[4-hydroxy-1-[(3R)-3-phenylbutanoyl]piperidin-4-yl]methyl]-2-methyl-7-oxopyrazolo[4,3-d]pyrimidin-3-yl]phenyl]methyl]propanamide is sourced from PubChem (CID 166555323), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).